miR-539 inhibits prostate cancer progression by directly targeting SPAG5
Crossref DOI link: https://doi.org/10.1186/s13046-016-0337-8
Published Online: 2016-04-01
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Hongtuan
Li, Shadan
Yang, Xiong
Qiao, Baomin
Zhang, Zhihong
Xu, Yong
Funding for this research was provided by:
National Natural Science Foundation of China (81502220)
Science Foundation of Tianjin medical university (2009GSI18)